MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

Overview of attention for article published in Journal of Clinical Oncology, January 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 18 news outlets
twitter: 9 X users

patent: 4 patents
reddit: 1 Redditor

Readers on

mendeley: 351 Mendeley

Summary News X Patents Reddit

So far, Altmetric has seen 4 patents that reference this research output.

Detection of MET exon 14 deletions and associated therapies

Grant US-11913072-B2

United States of America

Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation…

Grant US-11879013-B2

United States of America

ANTI-CMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE

Application EP-4233909-A2

European Patent Office

METHODS AND COMPOSITIONS FOR MODULATING HYPERSTABILIZED C-MET

Grant EP-1868648-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.